先进疗法的非临床开发:转化和监管成功的最佳实践
1Shanghai Medicilon Pharmaceutical Company, Shanghai, China.
Regulatory toxicology and pharmacology : RTP
|January 14, 2026
概括
开发先进的治疗方法需要综合的非临床研究,以获得监管成功. 本综述概述了细胞和基因疗法,抗体药物联合体和RNA药物的最佳实践,以加速安全的临床转化.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 监管科学 监管科学
- 生物技术是生物技术.
背景情况:
- 先进的治疗方法 (细胞/基因疗法,ADC,RNA药物) 面临着独特的临床前挑战.
- 研究新药 (IND) 和临床试验应用 (CTA) 研究的监管期望是复杂的和全球性的.
- 现有的非临床策略往往缺乏整合,阻碍了高效的翻译.
研究的目的:
- 综合最佳实践,设计用于先进治疗的IND/CTA启用研究.
- 将关键的非临床学科 (药理学,PK/PD,安全,毒理学) 整合到一个有凝聚力的战略中.
- 将非临床计划与全球监管预期 (FDA,EMA,PMDA) 和ICH指导相协调.
主要方法:
- 审查和综合当前的监管框架和科学文献.
- 生物分布,药理动力学/药理动力学 (PK/PD),免疫性,安全性药理学和毒理学的整合.
- 对瘤学和非瘤学适应症的模式特异性风险和考虑因素的分析.
主要成果:
- 建议综合策略,包括相关的动物模型和新的分析方法.
- 强调保守的首次人体剂量选择,以管理翻译不确定性.
- 突出了不同治疗方式和适用于不同疗法和适用于不同疗法的不同监管数据要求.
结论:
- 采用综合科学和监管策略简化了临床前开发.
- 预测监管问题,确保制造准备以及强有力的风险减缓至关重要.
- 这些方法加速向患者提供安全有效的先进疗法.
更多相关视频
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
2.8K
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
18.9K
相关概念视频
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Drug Products: Biologics, Biosimilars and Interchangeables
235
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
235
